TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 132 filers reported holding TG THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,976 | -99.2% | 197,884 | +197.8% | 0.04% | +600.0% |
Q3 2022 | $393,000 | +72.4% | 66,443 | +452.8% | 0.01% | +400.0% |
Q4 2021 | $228,000 | -68.7% | 12,020 | -45.1% | 0.00% | -66.7% |
Q3 2021 | $729,000 | +235.9% | 21,896 | +291.7% | 0.00% | +200.0% |
Q2 2021 | $217,000 | -79.2% | 5,590 | -74.1% | 0.00% | -80.0% |
Q1 2021 | $1,042,000 | +72.5% | 21,612 | +86.3% | 0.01% | +66.7% |
Q4 2020 | $604,000 | -57.0% | 11,603 | -77.9% | 0.00% | -66.7% |
Q3 2020 | $1,405,000 | +428.2% | 52,511 | +284.8% | 0.01% | +350.0% |
Q2 2020 | $266,000 | +60.2% | 13,645 | -19.0% | 0.00% | 0.0% |
Q1 2020 | $166,000 | +8.5% | 16,853 | -38.2% | 0.00% | +100.0% |
Q3 2019 | $153,000 | -42.7% | 27,266 | -11.6% | 0.00% | -50.0% |
Q2 2019 | $267,000 | +13.1% | 30,858 | +5.0% | 0.00% | 0.0% |
Q1 2019 | $236,000 | +50.3% | 29,377 | -23.3% | 0.00% | +100.0% |
Q4 2018 | $157,000 | +86.9% | 38,285 | +154.9% | 0.00% | 0.0% |
Q3 2018 | $84,000 | -22.9% | 15,022 | +117.6% | 0.00% | 0.0% |
Q4 2014 | $109,000 | – | 6,905 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
Parkwood LLC | 165,414 | $6,081 | 0.66% |
Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |